T. Hoffmann and R. Metternich, F. Hoffmann−La Roche Ltd., look at potential areas for drug R&D outside traditional medicinal chemistry

The Future of Medicinal Chemistry

Angewandte Chemie 19/2012: The Secret of Print
An overview of the latest issue of Angewandte Chemie

Combatting Designer Drugs Head On
New methods to help law enforcement keep up with the dizzying array of new designer drugs designed to escape detection

Thomas Scheuring on Organizing the ACHEMA Exhibition
T. Scheuring, CEO of DECHEMA Ausstellungs-GmbH, talks about what DECHEMA's reorganization means for the upcoming ACHEMA

Model Predicts Nanoparticle Toxicity
Model predicts toxicity of metal oxide nanoparticles based on electrical and solublity properties

Test Result Written in Blood
Paper-based blood test provides “written report” of blood type

New Immune Defence Enzyme
Previously unknown serine protease forms part of the antibacterial defense arsenal of neutrophil granulocytes

Antiviral Drug Strategies
Erik De Clercq' book, Antiviral Drug Strategies, is reviewed by Thomas W. Bell, USA

Angewandte Chemie 18/2012: No End in Sight
An overview of the latest issue of Angewandte Chemie

Simulated Digestion for Better Drug Delivery
Nanomaterial made from lipids and silicon dioxide improves absorption of pharmaceuticals by imitating the food effect